IP on Pharma Could be Main CETA Stumbling Block

John Ivison of the National Post reports that Canada and the EU are moving closer to a trade agreement, but that EU demands to extend IP protection for pharmaceuticals – a move that would cost Canadians millions – is viewed as a major stumbling block.

Comments are closed.